Personalized botulinum toxin type A therapy for cervical dystonia based on kinematic guidance

ConclusionClinical judgement guided by kinematic analysis of CD biomechanics can result in faster optimal muscle selections and minimize use of higher BoNT-A doses as compared to visual determination, thereby achieving comparable and potentially better treatment outcomes.
Source: Journal of Neurology - Category: Neurology Source Type: research